Medical Leadership

The ABOPM is actively searching for and inviting physician leaders in the field of precision medicine to join our Medical Leadership Board. We are looking for highly qualified individuals who can offer their expertise and insights to help achieve our mission. If you are an MD or DO who is passionate about advancing precision medicine and want to help close the gap from “bench to bedside”, we encourage you to apply. Your contributions will help shape the future of healthcare and empower physicians to provide the best care possible to patients. Join us today and be a leader in the exciting field of precision medicine.

  • Dr. Ben Schanker MD, MBA, MPH is a Preventive Medicine specialist at Stanford University, where he is Clinical Assistant Professor in the Division of Primary Care and Population Health. He is a graduate of Harvard Medical School, Johns Hopkins Bloomberg School of Public Health, and Oxford Said Business School. After preliminary Internal Medicine at Yale and residency/fellowship training at the University of California, San Francisco (UCSF), he practiced community health in California’s Central Valley, with a focus on treating neuromusculoskeletal and orthopedic spine/sports injuries. He brings over a decade of leadership experience in systems quality improvement to the board, having served as an Expert Consultant for the World Health Organization and on leadership teams of the American Medical Association Foundation and Massachusetts Medical Society. He is the father of bulldogs and enjoys organic farming and international travel in his free time.

Director of Precision Preventive Medicine

  • Andy R. Eugene, MD, PhD, FCP, DABCP is board-certified by the American Board of Clinical Pharmacology, a Fellow of the American College of Clinical Pharmacology, and is an expert on pharmacogenomics and adverse drug events. Dr. Eugene completed post-graduate training at the Mayo Clinic in Rochester, Minnesota in Clinical Pharmacology and later worked on the institutional-wide implementation of Pharmacogenomics for the Mayo Clinic Center for Individualized Medicine. Clinically, Dr. Eugene is credentialed in Psychiatry at Larned State Hospital, is an International Associate of the Royal College of Psychiatrists (UK), an Associate of the Royal College of Physicians (UK), and a Member of the American Medical Association.

    Dr. Eugene is experienced in EEG Brain Mapping in Psychopharmacology and has experience in Phase I Clinical Trials, Drug-Drug Interaction Studies, Clinical Trials in Clinical Pharmacology, Population Pharmacokinetics and Pharmacodynamics (PK/PD) Modeling and Simulation, Non-Compartmental Analysis and Toxicokinetic Analysis, Data Science with Genomics Single-Nucleotide Polymorphism Datasets, and has an interest in Pharmacovigilance analysis of Adverse Drug Events data from the US FDA Adverse Events Reporting System.

Director of Clinical Pharmacogenomics

  • Olivia Levine, MD, PhD is a neuropsychiatrist with expertise in addiction and mood disorders. Her PhD research focused on neural circuits, particularly a thalamic-amygdalar circuit involved in alcohol use and anxiety behaviors, uncovering key sex differences. During her medical training, she studied iron metabolism protein expression in schizophrenia patients. Dr. Levine is dedicated to understanding the molecular, circuit, and behavioral complexities of psychiatric disorders to inform targeted treatments.

Neuropsychiatry Adjunct Faculty

  • Dr. Saeed Shaikh, M.D.,F.R.C.P.C., is the co-founder of Precision Longevity Inc. and Director of the Niagara Peninsula Arthritis Centre. A native of Toronto, Dr. Shaikh received his Bachelor of Arts from the University of Toronto and Doctor of Medicine from the Royal College of Surgeons in Ireland. He completed his Residency in Internal Medicine at the Medical Center of Delaware and Fellowship in Rheumatology at Georgetown University in Washington, DC. He has completed board certifications in both Internal Medicine and Rheumatology in the United States and Canada. He has served on the Board of Directors for the Canadian Rheumatology Research Consortium and is currently an Assistant Clinical Professor at McMaster University. Dr. Shaikh also presently serves on the Scientific Advisory Council for Osteoporosis Canada and is an active member of the Healthy Longevity Medicine Society.

Director of Precision Rheumatology

  • Dr. Raffaele has been practicing longevity medicine for 25 years and has published clinical studies in telomere biology, epigenetics, hormone therapy, and glycobiology. He is the CEO and CMO of the software company he co-founded, PhysioAge Health Analytics, which enables longevity practices around the world to practice precision, n-of-1 longevity medicine more effectively than traditional EHRs. He routinely writes about longevity medicine on Raffaelemedical.com, PhysioAge.com, and @RaffaeleMD.

Director of Longevity Medicine